| Item | Cat. No. | Application | Isotype |
| Anti-Respiratory Syncytial Virus Glycoprotein F mAbs [Palivizumab Biosimilar] (MABL-5060) | MABL-5060 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGF mAbs [Palverafusp Biosimilar] (MABL-5061) | MABL-5061 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Pamlectabart Biosimilar] (MABL-5062) | MABL-5062 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Opamistomig Biosimilar] (MABL-5034) | MABL-5034 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
| Anti-KIT/CD117 mAbs [Opelkibart Biosimilar] (MABL-5035) | MABL-5035 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LINGO1 mAbs [Opicinumab Biosimilar] (MABL-5036) | MABL-5036 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EPCAM/CD326 mAbs [Oportuzumab Biosimilar] (MABL-5037) | MABL-5037 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-PDL1/CD274 mAbs [Opucolimab Biosimilar] (MABL-5038) | MABL-5038 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-FOLR1;FOLR1 mAbs [Opugotamig Biosimilar] (MABL-5039) | MABL-5039 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-IL15 mAbs [Ordesekimab Biosimilar] (MABL-5040) | MABL-5040 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FCGRT/FcRn mAbs [Orilanolimab Biosimilar] (MABL-5041) | MABL-5041 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1 mAbs [Ormutivimab Biosimilar] (MABL-5042) | MABL-5042 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-OxLDL mAbs [Orticumab Biosimilar] (MABL-5043) | MABL-5043 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-CLDN18 mAbs [Osemitamab Biosimilar] (MABL-5044) | MABL-5044 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F11 mAbs [Osocimab Biosimilar] (MABL-5045) | MABL-5045 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E mAbs [Otelixizumab Biosimilar] (MABL-5046) | MABL-5046 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-KDR/CD309/VEGFR2 mAbs [Olinvacimab Biosimilar] (MABL-5018) | MABL-5018 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-LGALS3/GAL3 mAbs [Oloctinebart Biosimilar] (MABL-5019) | MABL-5019 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL6 mAbs [Olokizumab Biosimilar] (MABL-5020) | MABL-5020 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IGHE mAbs [Omalizumab Biosimilar] (MABL-5021) | MABL-5021 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
